この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Emilie D.に依頼
France
Scientist project manager & writer I 16+ years of experience in therapy developpement research
プロフィール概要
専門分野
サービス
Writing
Clinical Trial Documentation,
Medical Writing,
Non-Medical Regulatory Writing,
Technical Writing,
Copywriting,
Newswriting,
Audio Transcription
Research
User Research,
Meta-Research,
Feasibility Study,
Technology Scouting,
Fact Checking,
Gap Analysis,
Gray Literature Search,
Scientific and Technical Research
Consulting
Business Strategy Consulting,
Scientific and Technical Consulting
Data & AI
Statistical Analysis,
Image Analysis,
Data Visualization
Product Development
Product Evaluation,
Material Sourcing,
Quality Assurance & Control (QA/QC)
職務経験
R&D project manager I Laboratory manager
Nervosave Therapeutics
1月 2023 - 6月 2024
R&D project manager I Responsible for rodent behavior analysis
Amylgen (preclinical CRO)
11月 2020 - 1月 2022
Fundamental project manager
Functional Genomic Institut of Montpellier
5月 2016 - 6月 2020
Clinical Research Associate (observational studies)
Mediaxe formation, Paris
11月 2015 - 4月 2016
PhD completion in neurobiology
Pierre and Marie Curie University - Paris Sorbonne
10月 2008 - 4月 2015
Fundamental research project manager in England
Medical Research Council at London
9月 2013 - 2月 2015
学歴
Doctorate in neurobiology
Pierre and Marie Curie University - Paris Sorbonne
1月 2025 - 1月 2025
M.Sc (Master of Science)
Pierre and Marie Curie University - Paris Sorbonne
9月 2007 - 9月 2008
Bachelors
Université Rennes I - France
9月 2003 - 6月 2007
認定資格
-
Quality in research
MOOC Ref. 66008
1月 2025 - 現在
-
Good Laboratory Pratices
Cefira, Paris
1月 2025 - 現在
-
Project management in pharmaceutical R&D
Ifis, Paris
1月 2025 - 現在
-
Team management
AIT Montpellier
1月 2025 - 現在
-
Experimental surgery
CNRS, Marseille
1月 2022 - 現在
-
Research animal experimentation, designer level
Biocampus Montpellier
1月 2016 - 現在
出版物
JOURNAL ARTICLE
Emilie Doucet, Katarzyna Grychowska, Paweł Zajdel, Joël Bockaert, Philippe Marin, carine bécamel (2021). Blockade of Serotonin 5-HT6 Receptor Constitutive Activity Alleviates Cognitive Deficits in a Preclinical Model of Neurofibromatosis Type 1 . International Journal of Molecular Sciences.
Coralie Berthoux, Al Mahdy Hamieh, Angelina Rogliardo, Emilie L Doucet, Camille Coudert, Fabrice Ango, Katarzyna Grychowska, Séverine Chaumont‐Dubel, Pawel Zajdel, Rafael Maldonado, et al. (2020). Early 5‐<scp>HT</scp><sub>6</sub>receptor blockade prevents symptom onset in a model of adolescent cannabis abuse . EMBO Molecular Medicine.
C Lanteri, E L Doucet, S J Hernández Vallejo, G Godeheu, A-C Bobadilla, L Salomon, L Lanfumey, J-P Tassin (2014). Repeated exposure to MDMA triggers long-term plasticity of noradrenergic and serotonergic neurons . Molecular Psychiatry.
Emilie L. Doucet, Ana-Clara Bobadilla, Vanessa Houades, Christophe Lanteri, Gérard Godeheu, Laurence Lanfumey, Susan J. Sara, Jean-Pol Tassin (2013). Sustained Impairment of α2A-Adrenergic Autoreceptor Signaling Mediates Neurochemical and Behavioral Sensitization to Amphetamine . Biological Psychiatry.
Christophe Lanteri, Sandra Jimena Hernández Vallejo, Lucas Salomon, Emilie Lucie Doucet, Gérard Godeheu, Yvette Torrens, Vanessa Houades, Jean-Pol Tassin (2009). Inhibition of Monoamine Oxidases Desensitizes 5-HT<sub>1A</sub>Autoreceptors and Allows Nicotine to Induce a Neurochemical and Behavioral Sensitization . The Journal of Neuroscience.